Grove Biopharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Grove Biopharma Launches with a Novel Biotherapeutic Modality Platform; Portal Innovations Leads Oversubscribed Seed-Stage Investment
Share Article
Leverages Biomaterial Discoveries and Insights from Award Winning Scientist Nathan Gianneschi, Ph.D. With an Initial Focus on Neurodegenerative Diseases
Professor Gianneschi’s protein-like polymer (PLP) platform is a revolutionary innovation at the interface between materials engineering, biology, chemistry, and data science with the potential to address important biological disease targets including those classically considered to be undruggable.
CHICAGO (PRWEB)
May 10, 2021
Portal Innovations, a premier life sciences venture development engine, today announced that Grove Biopharma has successfully closed an oversubscribed $4 million seed round and will become a portfolio member at its Fulton Labs location. Other noteworthy participants in the ....

United States , San Diego , John Flavin , Joe Mansueto , Paul Bertin , Geoff Duyk , Jacob Rosaline Cohn , University Of California , Biomedical Engineering At Northwestern University , Northwestern University , Grove Biopharma Inc , Professor Gianneschi , Grove Biopharma , Fulton Labs , Skydeck Capital , Rosaline Cohn Professor , Materials Science , Biomedical Engineering , Portal Innovations , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , ஜான் ஃபிளாவின் , பால் பெர்டின் , ஜாகோப் ரோசலின் கோன் , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா , உயிர் மருத்துவ பொறியியல் இல் வடமேற்கு பல்கலைக்கழகம் ,